Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case-control study.
Subject-Specific Sparse Dictionary Learning for Atlas-Based Brain MRI Segmentation.
Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
Blind analysis: Hide results to seek the truth.
Myeloid cells as target of fingolimod action in multiple sclerosis.
Impaired health-related quality of life predicts progression of disability in multiple sclerosis.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Preliminary evaluation of variable compliance joystick for people with multiple sclerosis.
Ethical considerations when counseling patients about stem cell tourism.
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study.
The Swedish MS registry - clinical support tool and scientific resource.
Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis-Reply.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.
Vitamin D in multiple sclerosis: implications for assessment and treatment.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Role of STIM-dependent Ca(2+) Influx in Regulatory B Cells.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
Genomic Characterization of Japanese Macaque Rhadinovirus: A Novel Herpesvirus Isolated from a Nonhuman Primate with a Spontaneous Inflammatory Demyelinating Disease.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Multiple sclerosis: individualized disease susceptibility and therapy response.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Pages
« first
‹ previous
…
392
393
394
395
396
397
398
399
400
…
next ›
last »